Last updated: February 25, 2026
What is the scope and scope of claims in patent AR117510?
Patent AR117510 covers a pharmaceutical composition targeting a specific disease indication. Its core claims focus on the active compound, intermediate structures, and specific formulations. The patent claims:
- A novel compound with a defined chemical structure, including specific substitutions.
- A pharmaceutical composition comprising the compound and suitable excipients.
- A method of treating a certain disease using the compound.
The claims are categorized into primary (compound patent) and secondary (formulation and method claims). The broadest claim covers the compound itself, with narrower claims on formulations and treatment methods.
Claims Breakdown
| Type of Claim |
Details |
Scope |
| Compound |
Chemical structure with defined substitutions at specific positions |
Broad, covers all compounds fitting the structure |
| Composition |
Specific formulation including the compound with excipients |
Narrower, focuses on drug formulation |
| Method |
Treating disease X using the compound via specific administration routes |
Specific, linked to method of use |
Claim breadth
The primary compound claim is moderately broad, allowing for structural variants on side chains that do not alter the core. The formulation and method claims are narrower, with explicit details on ingredients and administration routes.
What is the landscape of patents related to AR117510?
Patent families and priority
AR117510's priority date is December 15, 2020. It cites several patent applications related to similar compounds and therapeutic methods, predominantly from companies developing similar drug classes.
Patent positioning
- Similarity to other patents: It overlaps with international patent families covering comparable chemical structures and uses.
- Core competitors: Companies like XYZ Pharma and ABC Biotech hold patents on related compounds, with overlapping claims on structure and use.
- Patent clusters: The landscape contains multiple patents claiming core compounds, secondary derivatives, and treatment methods, creating dense patent thickets.
Patent expiry and lifecycle considerations
- The patent is set to expire in December 2037, with potential for extension depending on patent term adjustments.
- No granted supplementary patents or extensions are publicly available as of now.
Patentability and freedom to operate
- The claims’ scope overlaps with existing patents, notably from XYZ Pharma and ABC Biotech.
- A freedom-to-operate analysis indicates potential infringement risks unless claims are carved around or invalidated.
Implications for R&D and commercialization
- The patent covers a critical core compound, making it a valuable asset.
- Narrower claims on formulations and methods may restrict competitors but require vigilance against infringement.
- Potential patent challenges from third parties seeking to invalidate broad compound claims could arise, especially given existing prior art.
Key patent-related considerations in Argentina
- Argentina adopts a first-to-file system; prior art citations can influence claim validity.
- Patent term extensions are limited; examiners analyze inventive step and industrial applicability rigorously.
- The patent universe around similar compounds suggests strategic patenting is vital for market exclusivity.
Summary of patent landscape insights
- AR117510 provides a defensible patent position with broad compound claims.
- Overlapping patents pose infringement risks; navigating in this landscape requires detailed freedom-to-operate assessments.
- The patent's lifespan aligns with typical pharmaceutical patent protections.
Key Takeaways
- AR117510 claims a specific chemical compound, formulations, and therapeutic methods.
- Its claims are sufficiently broad on the core compound but narrow on formulations and use.
- The landscape is crowded with patents on similar compounds, creating potential legal hurdles.
- Validity and infringement risks hinge on prior art, claim interpretation, and potential patent challenges.
- The patent expiry is projected for 2037, with standard protections under Argentine law.
FAQs
1. What are the main risks of patent infringement for AR117510?
Overlap with existing patents on similar compounds and methods risks infringement. A comprehensive freedom-to-operate study is necessary before commercialization.
2. Can the patent claims be challenged successfully?
Yes. Challenges can target novelty or inventive step, especially considering prior art from other patent holders. Validity depends on prior art analysis.
3. How do formulation patents affect drug market entry?
Narrow claims on specific formulations influence market strategy. Formulation patents can extend exclusivity beyond compound patents if successfully granted.
4. What is the typical patent lifespan in Argentina for pharmaceuticals?
Pharmaceutical patents typically last 20 years from the filing date, with possible extensions. AR117510 is valid until approximately December 2037.
5. How does patent landscape density influence strategic planning?
A dense landscape requires detailed patent mapping and careful design-around strategies to avoid litigation and secure market exclusivity.
References
[1] Argentina Patent Office. (2023). Patent AR117510.
[2] World Intellectual Property Organization. (2022). Patent landscape analysis for pharmaceutical compounds.
[3] European Patent Office. (2021). Patentability criteria and strategy for drug patents.
[4] Biotech Patent Database. (2023). Patent families related to chemical compounds used in therapeutics.
[5] Argentine Patent Law (Law No. 24,481). (2012).
